Clinical Trial Update: A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating anlotinib hydrochloride capsules added to chemotherapy as first-line treatment for metastatic colorectal cancer that is RAS/BRAF wild-t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Anlotinib hydrochloride capsule (Anlotinib hydrochloride)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING